+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Octapharma AG - logo

Octapharma is a privately-owned global human proteins manufacturer headquartered in Lachen, Switzerland. It develops human proteins that are derived from human plasma and human cell-lines. The company provides biopharmaceutical products and therapies for haematology, intensive care & emergency medicine, and immunotherapy. Octapharma owns and operates six state of the art plants, employing over 6,000 workers globally. It was founded in 1983 by Wolfgang Marguerre.

From
Blood Plasma Derivatives Market Report 2026 - Product Thumbnail Image

Blood Plasma Derivatives Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Bleeding Disorders Treatment Market Report 2026 - Product Thumbnail Image

Bleeding Disorders Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Thalassemia Treatment Market - Global Forecast 2026-2032 - Product Thumbnail Image

Thalassemia Treatment Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 196 Pages
  • Global
From
From
Coagulation Factor Concentrates Market - Global Forecast 2026-2032 - Product Thumbnail Image

Coagulation Factor Concentrates Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 182 Pages
  • Global
From
Human Fibrin Sealant Kit Market - Global Forecast 2026-2032 - Product Thumbnail Image

Human Fibrin Sealant Kit Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 187 Pages
  • Global
From
Factor IX Complex Concentrate Market - Global Forecast 2026-2032 - Product Thumbnail Image

Factor IX Complex Concentrate Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 184 Pages
  • Global
From
From
Human Factor VIII Concentrate Market - Global Forecast 2026-2032 - Product Thumbnail Image

Human Factor VIII Concentrate Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 199 Pages
  • Global
From
Plasma-Derived Medicines - Global Strategic Business Report - Product Thumbnail Image

Plasma-Derived Medicines - Global Strategic Business Report

  • Report
  • November 2026
  • 391 Pages
  • Global
From
From
From
Loading Indicator